NCT01345266View on ClinicalTrials.gov

Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry

PHASE1CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

February 1, 2010

Primary Completion Date

June 28, 2010

Study Completion Date

June 28, 2010

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
PROCEDURE

Inhalation Profiling

All subects recieve Inhaltion Profiling there are no interventions.

Trial Locations (2)

2060

GSK Investigational Site, Antwerp

2650

GSK Investigational Site, Edegem

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01345266 - Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry | Biotech Hunter | Biotech Hunter